1Al- Hajj M, Wicha MS, Benito - Hemandez A, et al. Prospective identification of tumorigenic breast cancer cells [ J ]. Proc Natl Acad Sci USA ,2003,100(7 ) :3983 - 3988.
2Dick JE. Breast cancer stem cells revealed [ J] . Proc Natl Acad Sci USA,2003,100(7) :3547 -3549.
3Clarke RB. Isolation and characterization of human mammary stem cells [ J ]. Cell Prolif,2005,38 ( 6 ) : 375 - 386.
4Vaillant F, Asselin - Labat ML, Shackleton M,et al. The emerging picture of the mouse mammary stem cell[J]. Stem Cell Rev, 2007,3(2) :114 - 123.
6Narod SA, Foulkes WD. BRCA1 and BRCA2:1994 and beyond [J]. Nat Rev Cancer,2004,4(9) :665 -676.
7Buzdar AU, Vergote I, Sainsbury R. The impact of hormone receptor status on the clinical efficacy of the new - generation aromatase inhibitors: a review of data from first - line metastatic disease trials in postmenopausal women [ J]. Breast J,2004,10 (3) : 211 -217.
8Dontu G, El- Ashry D, Wicha MS. Breast cancer, stem/progenitor cells and the estrogen receptor [ J]. Trends Endocrinol Metab, 2004,15(5) :193 -197.
9HahnH, Wicking C, Zaphiropoulous PG,et al. Mutations of the human homolog of Drosophila patched in the uevoid basal cell carcinoma syndrome [ J ]. Cell, 1996,85 ( 6 ) : 841 - 851.
10Reya T, Morrison SJ, Clarke MF,et al. Stem cells, cancer, and cancer stem ceils [J]. Nature, 2001, 414 (6859) :105-111.
3Oliveira LR, Jeffrey SS, Ribeiro - Silva A. Stem cells in human breast cancer [ J ]. Histol Histopathol,2010,25 (3) :371 - 385.
4Nguyen NP, Almeida FS, Chi A, et al. Molecular biology of breast cancer stem cells: potential clinical applications [ J]. Cancer Treat Rev,2010,36(6) :485 -491.
5Abraham BK, Fritz P, McClellan M, et al. Prevalence of CD44 + / CD24 -/low cells in breast cancer may not be associated with clin- ical outcome but may favor distant metastasis [ J ]. Clin CancerRes.2005.11(3):1154 -1159.
6Paltian V, Alldinger S, Baumgairtner W, et al. Expression of CD44 in canine mammary tumours [ J]. J Comp Pathol,2009, 141 (4) :237 -247.
7Madjd Z, Mehrjerdi AZ, Sharifi AM, et al. CIM4 + cancer cells express higher levels of the anti - apoptotic protein Bcl - 2 in breast tumours [J]. Cancer lmmun,2009 ,9 :4.
8Wang SJ, Wreesmann VB, Bourguignon LY. Association of CD44 V3containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node me- tastasis in head and neck cancer [ J ]. Head Neck, 2007,29 (6) :550 -558.
9Lee H J, Choe G, Jheon S, ct al. CD24, a novel cancer biomark- er, predicting disease -free survival of nonsmall cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification [J]. J Thorac 0ncol,2010,5(5) :649 -657.
10Rakha EA, Reis-Filho JS, Ellis IO. Impact of basal-like breast carcino- ma determination for a more specific therapy [ J ]. Patholbiol, 2008,75 (2) :95-103.
